Pub. Date : 2022
PMID : 35418865
4 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
1 | Here, we demonstrate that Ag120 (ivosidenib), a mutant isocitrate dehydrogenase 1 (IDH1) inhibitor approved for the treatment of certain cancers, acts as an ASCT2 inhibitor in CRC cells. | ivosidenib | isocitrate dehydrogenase (NADP(+)) 1 | Homo sapiens |
2 | Here, we demonstrate that Ag120 (ivosidenib), a mutant isocitrate dehydrogenase 1 (IDH1) inhibitor approved for the treatment of certain cancers, acts as an ASCT2 inhibitor in CRC cells. | ivosidenib | isocitrate dehydrogenase (NADP(+)) 1 | Homo sapiens |
3 | Here, we demonstrate that Ag120 (ivosidenib), a mutant isocitrate dehydrogenase 1 (IDH1) inhibitor approved for the treatment of certain cancers, acts as an ASCT2 inhibitor in CRC cells. | ivosidenib | isocitrate dehydrogenase (NADP(+)) 1 | Homo sapiens |
4 | Here, we demonstrate that Ag120 (ivosidenib), a mutant isocitrate dehydrogenase 1 (IDH1) inhibitor approved for the treatment of certain cancers, acts as an ASCT2 inhibitor in CRC cells. | ivosidenib | isocitrate dehydrogenase (NADP(+)) 1 | Homo sapiens |